🇺🇸 Vasopressors in United States
91 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 91
Most-reported reactions
- Hypotension — 17 reports (18.68%)
- Toxicity To Various Agents — 12 reports (13.19%)
- Metabolic Acidosis — 11 reports (12.09%)
- Multi-Organ Failure — 9 reports (9.89%)
- Respiratory Failure — 8 reports (8.79%)
- Sepsis — 8 reports (8.79%)
- Coma — 7 reports (7.69%)
- Death — 7 reports (7.69%)
- Depressed Level Of Consciousness — 6 reports (6.59%)
- Haematocrit Decreased — 6 reports (6.59%)
Other Other approved in United States
Frequently asked questions
Is Vasopressors approved in United States?
Vasopressors does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Vasopressors in United States?
Chulalongkorn University is the originator. The local marketing authorisation holder may differ — check the official source linked above.